Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 9,488 | 8,189 | 17,297 | 10,797 | 8,182 |
| Operating Income | -9,488 | -8,189 | -17,297 | -10,797 | -8,182 |
| Interest Expense | 980 | 1,008 | 678 | 1,100 | 542 |
| Other Income | 415 | 413 | 230 | 1,018 | -58 |
| Pre-tax Income | -10,053 | -8,784 | -17,745 | -10,879 | -8,782 |
| Net Income Continuous | -10,053 | -8,784 | -17,745 | -10,879 | -8,782 |
| Net Income | $-10,053 | $-8,784 | $-17,745 | $-10,879 | $-8,782 |
| EPS Basic Total Ops | -2.27 | -2.05 | -4.24 | -2.60 | -2.11 |
| EPS Basic Continuous Ops | -2.27 | -2.05 | -4.24 | -2.61 | -2.11 |
| EPS Diluted Total Ops | -2.27 | -2.05 | -4.24 | -2.60 | -2.11 |
| EPS Diluted Continuous Ops | -2.27 | -2.05 | -4.24 | -2.61 | -2.11 |
| EBITDA(a) | $-9,278 | $-7,879 | $-17,116 | $-10,518 | $-8,237 |